March 28, 2014
In February, FDA issued an import alert for kratom that effectively cut U.S. supply to the botanical. According to DEA, the new dietary ingredient has no legitimate medical use, and can lead to addiction and psychotic symptoms. FDA's import alert affected 27 companies, and another has pulled kratom from shelves in a voluntary recall.
In this week's News Desk, INSIDER presents industry reaction to the import alert and current legislation targeting the ingredient and its components.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023